Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| NICHD Small Research Grant Program (R03 Clinical Trial Required) | PA-25-125 | NICHD | The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission. | ||
| Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required) | RFA-DA-25-057 | NIDA | Stimulant Use Disorder still does not have FDA- approved treatments. Neuromodulation, such as, for example, transcranial magnetic stimulation (TMC) has been successfully used for more than 10 years… More | ||
| Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional) | RFA-DA-25-050 | NIDA | This notice of funding opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grants applications from small business concerns (SBC) proposing research and development of solutions… More | ||
| Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional) | RFA-DA-25-049 | NIDA | This funding opportunity calls for developing novel solutions targeted to improve health outcomes and reduce the impact of adverse health consequences in people who use drugs. These solutions should… More | ||
| Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U24 Clinical Trial Not Allowed) | RFA-DA-25-038 | NIDA | This Notice of Funding Opportunity (NOFO) invites applications for a Data Coordination Center (DCC) for the Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk… More | ||
| Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed) | RFA-DA-25-056 | NIDA | There is a lack of early translational funding and technical support for new product developers to move beyond the idea stage and into the product development space. Establishing a technical… More | ||
| Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) | RFA-DA-25-039 | NIDA | This concept proposes to advance methodological rigor in NIDA-relevant research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral,… More | ||
| Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience | NOT-DA-21-030 | NIDA | This Notice of Special Interest [NOSI] is to support computational HIV/AIDS research as it relates to NIDAs mission through collaborative research between investigators with experimental expertise… More | ||
| Notice of Special Interest: Advanced Computational Approaches to Elucidate Disease Pathology and Identify Novel Therapeutics for Addiction | NOT-DA-21-004 | NIDA | The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse (NIDA) of NIDA's interest in grant applications that will develop or utilize advanced… More | ||
| HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional) | RFA-DA-25-026 | NIDA | Individuals in the US justice system are disproportionately likely to have SUD/OUD, are at high risk for opioid withdrawal upon incarceration, and are at elevated risk for overdose post-release if… More |